Latest News about GSK
Recent news which mentions GSK
Is Xenon Pharmaceuticals a Good Stock to Buy Now?
October 05, 2021
From Motley Fool
Tesla and Merck Give Investors Some Hope
October 04, 2021
From Benzinga
Here's a High-Yield Dividend Stock Wall Street Thinks Could Jump 26% Within 12 Months
October 04, 2021
From Motley Fool
From MarketWatch
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
September 30, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Why Alexandria Real Estate May Be a Dividend Investor's Dream
September 29, 2021
From Motley Fool
ViiV Healthcare's Dovato Combo Regime Shows Encouraging Long Term Data In HIV Patients
September 29, 2021
From Benzinga
ViiV In-Licenses Third-Gen HIV Targeting Compound From Shionogi
September 28, 2021
From Benzinga
GSK, Pfizer Backed Long-Acting HIV Med Under FDA Priority Review As Preventative Option
September 28, 2021
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know
September 28, 2021
From Benzinga
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
From Benzinga
Analyst Upgrades Sanofi On COVID-19 Vaccine Optimism
September 27, 2021
From Benzinga
2 Best Biotech Stocks to Buy Right Now
September 25, 2021
From Motley Fool
Why Vir Biotechnology Stock Is Sinking This Week
September 24, 2021
From Motley Fool
Green Hygienics Holdings To Raise $100M Via Green Bond Offering
September 22, 2021
From Benzinga
Here's Why I Bought This Recent Genetics IPO
September 22, 2021
From Motley Fool
Here's Why Moderna's Stock Could Crash Before the End of 2021
September 19, 2021
From Motley Fool
5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch
September 18, 2021
From Motley Fool
7 SPACs to Buy That Are Better Than Bill Ackman’s Pershing Square Tontine
September 15, 2021
From InvestorPlace
Why Are Theravance Bio Shares Plummeting Premarket Today?
September 15, 2021
From Benzinga
3 Stocks I Bought That Could Produce 10X Returns
September 15, 2021
From Motley Fool
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
September 14, 2021
From Benzinga
Pete Najarian Sees Unusual Options Activity In Capri Holdings And GlaxoSmithKline
September 13, 2021
From Benzinga
These Promising Clinical Results Could Be Huge for Amgen Investors
September 11, 2021
From Motley Fool
Could This Be Pfizer's Next Blockbuster Vaccine?
September 10, 2021
From Motley Fool
Here's the Next Blockbuster Vaccine Opportunity for Pfizer
September 10, 2021
From Motley Fool
Why Alector Shares Are Diving Today
September 08, 2021
From Motley Fool
White House Commits $3B To Boost COVID-19 Vaccine Supply Chain: Report
September 03, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.